Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special Populations
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) Pathogens
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy Care
    Release Date:
    Partner: The Japanese Society for Cutaneous Immunology and Allergy
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UK
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine United Kingdom
    Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)
    Release Date:
    Partner: ALK Positive
    Review Process: Pfizer Internal
    Education Oncology All
    Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Canada, USA
    Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease China
    Real-World Atopic Dermatitis: Italian Insights Grant
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Promote Understanding of Respiratory Infections (Streptococcus pneumoniae, Influenza virus, RSV, GBS, SARS-Cov-2)
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Increasing the Awareness of the Importance of Vaccination during Pregnancy
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines Japan
    Understanding Alopecia Areata for Dermatologists, Pediatric Dermatologists, and Advanced Practice Providers
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Capacity Building for Antimicrobial Stewardship
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Japan
    Implementation of Systemic Treatment Approaches in Atopic Dermatitis
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Inflammation & Immunology China
    Oncology Capacity Building in Sub-Saharan Africa (including CABO VERDE and ESWATINI)
    Release Date:
    Partner: Mayo Clinic Global Bridges Oncology
    Review Process: Expert Review Panel
    Translation: French (link)
    Translation:(link)
    Quality Improvement Oncology Angola, Benin, Botswana, Burkina Faso, Burundi, Cameroon, Central African Republic, Chad, Comoros, Congo, Congo, The Democratic Republic, Cote D'ivoire, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guinea, Guinea-bissau, Kenya, Lesotho, Liberia, Madagascar, Malawi, Mali, Mauritania, Mauritius, Mozambique, Namibia, Niger, Nigeria, Rwanda, Sao Tome and Principe, Senegal, Seychelles, Sierra Leone, Somalia, South Africa, Sudan, Tanzania, United Republic of, Togo, Uganda, Zambia, Zimbabwe
    Improving Clinical Management for Patients with Breast Cancer in China
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology China
    NSCLC Cancer Precision Diagnosis and Treatment
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology China
    Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism
    Release Date:
    Partner: BMS
    Review Process: Pfizer Internal
    Education Internal Medicine All
    Addressing Knowledge Gaps in Aplastic Anemia
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Knowledge Gaps in Treatment of Acute COVID-19 and Management of Post-COVID Conditions in Outpatient Settings
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All
    Digital Education to Address Patients with COVID-19 and High Risk of Complications
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital All